CORCEPT THERAPEUTICS INC Long-Term Debt
CORCEPT THERAPEUTICS INC (CORT) had Long-Term Debt of $0 as of 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebtNoncurrent · last filed 2018-02-28
- 2017-12-31: Long-term Debt, Excluding Current Maturities $0.00.
- 2017-09-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2017-06-30: Long-term Debt, Excluding Current Maturities $0.00.
- 2017-03-31: Long-term Debt, Excluding Current Maturities $0.00.
| Period end | Long-term Debt, Excluding Current Maturities | Long-term Debt, Excluding Current Maturities as first filed |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-28 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $0.00 10-K · filed 2018-02-28 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $3.74M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $8.72M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $12.53M 10-K · filed 2017-03-06 | $12.56M 10-K · filed 2016-03-10 |
| 2015-09-30 | $16.13M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $19.40M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $22.13M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $24.46M 10-K · filed 2016-03-10 | |
| 2014-09-30 | $25.99M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $27.64M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $28.22M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $29.32M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $30.14M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $30.24M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $28.89M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $29.03M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $28.32M 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |